X-16946971-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004726.3(REPS2):c.110G>A(p.Cys37Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000373 in 911,644 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., 4 hem., cov: 21)
Exomes 𝑓: 0.000019 ( 0 hom. 4 hem. )
Consequence
REPS2
NM_004726.3 missense
NM_004726.3 missense
Scores
2
3
12
Clinical Significance
Conservation
PhyloP100: 5.06
Genes affected
REPS2 (HGNC:9963): (RALBP1 associated Eps domain containing 2) The product of this gene is part of a protein complex that regulates the endocytosis of growth factor receptors. The encoded protein directly interacts with a GTPase activating protein that functions downstream of the small G protein Ral. Its expression can negatively affect receptor internalization and inhibit growth factor signaling. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0138757825).
BS2
High Hemizygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
REPS2 | NM_004726.3 | c.110G>A | p.Cys37Tyr | missense_variant | 1/18 | ENST00000357277.8 | NP_004717.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
REPS2 | ENST00000357277.8 | c.110G>A | p.Cys37Tyr | missense_variant | 1/18 | 1 | NM_004726.3 | ENSP00000349824.3 | ||
REPS2 | ENST00000303843.7 | c.110G>A | p.Cys37Tyr | missense_variant | 1/18 | 1 | ENSP00000306033.7 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 19AN: 107503Hom.: 0 Cov.: 21 AF XY: 0.000129 AC XY: 4AN XY: 31095
GnomAD3 genomes
AF:
AC:
19
AN:
107503
Hom.:
Cov.:
21
AF XY:
AC XY:
4
AN XY:
31095
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000989 AC: 7AN: 7081Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 821
GnomAD3 exomes
AF:
AC:
7
AN:
7081
Hom.:
AF XY:
AC XY:
0
AN XY:
821
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000187 AC: 15AN: 804141Hom.: 0 Cov.: 29 AF XY: 0.0000160 AC XY: 4AN XY: 249583
GnomAD4 exome
AF:
AC:
15
AN:
804141
Hom.:
Cov.:
29
AF XY:
AC XY:
4
AN XY:
249583
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000177 AC: 19AN: 107503Hom.: 0 Cov.: 21 AF XY: 0.000129 AC XY: 4AN XY: 31095
GnomAD4 genome
AF:
AC:
19
AN:
107503
Hom.:
Cov.:
21
AF XY:
AC XY:
4
AN XY:
31095
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 13, 2023 | The c.110G>A (p.C37Y) alteration is located in exon 1 (coding exon 1) of the REPS2 gene. This alteration results from a G to A substitution at nucleotide position 110, causing the cysteine (C) at amino acid position 37 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Gain of phosphorylation at C37 (P = 0.0241);Gain of phosphorylation at C37 (P = 0.0241);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at